Search research articles
Contact Us
Filters
Showing results (281-290 of 298) with videos related to
Page
of 30
Sort By:
JAMA Cardiology
|
February 21, 2024
Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial
Michael T Lu, Heather Ribaudo, Borek Foldyna, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 6, 2025
Clonal Hematopoiesis and Major Adverse Cardiac Events in People With HIV: Insights From the REPRIEVE Trial
Liying Xue, Romit Bhattacharya, Md Mesbah Uddin, et al.
Nature Microbiology
|
October 27, 2022
Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial
Manish C Choudhary, Kara W Chew, Rinki Deo, et al.
The New England Journal of Medicine
|
November 3, 2016
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
Mary G Fowler, Min Qin, Susan A Fiscus, et al.
The New England Journal of Medicine
|
July 24, 2023
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection
Steven K Grinspoon, Kathleen V Fitch, Markella V Zanni, et al.
The Lancet. HIV
|
March 30, 2026
Risk of obesity, diabetes, hypertension, and major adverse cardiovascular events after a switch to an integrase inhibitor: a target trial emulation in REPRIEVE
Emma M Kileel, Carlos D Malvestutto, Markella V Zanni, et al.
Open Forum Infectious Diseases
|
October 23, 2023
Biological and Clinical Implications of the Vascular Endothelial Growth Factor Coreceptor Neuropilin-1 in Human Immunodeficiency Virus
Samuel R Schnittman, Márton Kolossváry, Gabriele Beck-Engeser, et al.
The Journal of Infectious Diseases
|
July 10, 2020
Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial
Tomas G Neilan, Kim-Lien Nguyen, Vlad G Zaha, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 24, 2023
Early Treatment, Inflammation and Post-COVID Conditions
Kelly A Gebo, Sonya L Heath, Yuriko Fukuta, et al.
Mbio
|
September 19, 2023
Early antibody treatment, inflammation, and risk of post-COVID conditions
Kelly A Gebo, Sonya L Heath, Yuriko Fukuta, et al.
Page
of 30
Search research articles
Search
Showing results (281-290 of 298) with videos related to
Sort By:
Page
of 30
JAMA Cardiology
|
February 21, 2024
Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial
Michael T Lu, Heather Ribaudo, Borek Foldyna, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 6, 2025
Clonal Hematopoiesis and Major Adverse Cardiac Events in People With HIV: Insights From the REPRIEVE Trial
Liying Xue, Romit Bhattacharya, Md Mesbah Uddin, et al.
Nature Microbiology
|
October 27, 2022
Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial
Manish C Choudhary, Kara W Chew, Rinki Deo, et al.
The New England Journal of Medicine
|
November 3, 2016
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
Mary G Fowler, Min Qin, Susan A Fiscus, et al.
The New England Journal of Medicine
|
July 24, 2023
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection
Steven K Grinspoon, Kathleen V Fitch, Markella V Zanni, et al.
The Lancet. HIV
|
March 30, 2026
Risk of obesity, diabetes, hypertension, and major adverse cardiovascular events after a switch to an integrase inhibitor: a target trial emulation in REPRIEVE
Emma M Kileel, Carlos D Malvestutto, Markella V Zanni, et al.
Open Forum Infectious Diseases
|
October 23, 2023
Biological and Clinical Implications of the Vascular Endothelial Growth Factor Coreceptor Neuropilin-1 in Human Immunodeficiency Virus
Samuel R Schnittman, Márton Kolossváry, Gabriele Beck-Engeser, et al.
The Journal of Infectious Diseases
|
July 10, 2020
Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial
Tomas G Neilan, Kim-Lien Nguyen, Vlad G Zaha, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 24, 2023
Early Treatment, Inflammation and Post-COVID Conditions
Kelly A Gebo, Sonya L Heath, Yuriko Fukuta, et al.
Mbio
|
September 19, 2023
Early antibody treatment, inflammation, and risk of post-COVID conditions
Kelly A Gebo, Sonya L Heath, Yuriko Fukuta, et al.
Page
of 30